Is the $6 Billion Medicare Deal a Game Changer or Just a Baby Step?
In recent news, the White House has made a significant announcement that marks a new chapter in health care policy. This development is the culmination of years of tireless effort: For the first time, the U.S. government has successfully negotiated drug prices directly with pharmaceutical companies. This achievement is noteworthy because the battle to reduce health care costs has always been daunting; thus, Medicare’s new ability to negotiate marks a pivotal moment. In the United States, an estimated 18 million people struggle to afford essential medications. As a result, any reduction in drug prices is likely to have a substantial…
